
New Medical Materials and Biomaterials Industry Research Report 2024
Description
New Medical Materials and Biomaterials Industry Research Report 2024
Summary
New Medical Materials and Biomaterials is newly developed materials for medical devices, tools, and other things (excluding drugs).
According to APO Research, The global New Medical Materials and Biomaterials market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for New Medical Materials and Biomaterials is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for New Medical Materials and Biomaterials is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for New Medical Materials and Biomaterials is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of New Medical Materials and Biomaterials include STR, Avitus, Sagemax, Stratasys, Formlab, NanoH2O (LG), Covalent-coating, Nasseo and TriboFilm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for New Medical Materials and Biomaterials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding New Medical Materials and Biomaterials.
The New Medical Materials and Biomaterials market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global New Medical Materials and Biomaterials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
STR
Avitus
Sagemax
Stratasys
Formlab
NanoH2O (LG)
Covalent-coating
Nasseo
TriboFilm
ACS material
Palmaz Scientific
Invibio
Secant Medical
TeraPore Technologies
New Medical Materials and Biomaterials segment by Type
Medical Polymers
Bioceramics
Medical 3D Printing Materials
Membranes
Surface Modifications
Others
New Medical Materials and Biomaterials Segment by Application
Packaging
Transplant Components
Dental Products
Catheters
Others
New Medical Materials and Biomaterials Segment by Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global New Medical Materials and Biomaterials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of New Medical Materials and Biomaterials and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of New Medical Materials and Biomaterials.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of New Medical Materials and Biomaterials companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Table of Contents
117 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 New Medical Materials and Biomaterials by Type
- 2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
- 2.2.2 Medical Polymers
- 2.2.3 Bioceramics
- 2.2.4 Medical 3D Printing Materials
- 2.2.5 Membranes
- 2.2.6 Surface Modifications
- 2.2.7 Others
- 2.3 New Medical Materials and Biomaterials by Application
- 2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
- 2.3.2 Packaging
- 2.3.3 Transplant Components
- 2.3.4 Dental Products
- 2.3.5 Catheters
- 2.3.6 Others
- 2.4 Assumptions and Limitations
- 3 New Medical Materials and Biomaterials Breakdown Data by Type
- 3.1 Global New Medical Materials and Biomaterials Historic Market Size by Type (2019-2024)
- 3.2 Global New Medical Materials and Biomaterials Forecasted Market Size by Type (2025-2030)
- 4 New Medical Materials and Biomaterials Breakdown Data by Application
- 4.1 Global New Medical Materials and Biomaterials Historic Market Size by Application (2019-2024)
- 4.2 Global New Medical Materials and Biomaterials Forecasted Market Size by Application (2019-2024)
- 5 Global Growth Trends
- 5.1 Global New Medical Materials and Biomaterials Market Perspective (2019-2030)
- 5.2 Global New Medical Materials and Biomaterials Growth Trends by Region
- 5.2.1 Global New Medical Materials and Biomaterials Market Size by Region: 2019 VS 2023 VS 2030
- 5.2.2 New Medical Materials and Biomaterials Historic Market Size by Region (2019-2024)
- 5.2.3 New Medical Materials and Biomaterials Forecasted Market Size by Region (2025-2030)
- 5.3 New Medical Materials and Biomaterials Market Dynamics
- 5.3.1 New Medical Materials and Biomaterials Industry Trends
- 5.3.2 New Medical Materials and Biomaterials Market Drivers
- 5.3.3 New Medical Materials and Biomaterials Market Challenges
- 5.3.4 New Medical Materials and Biomaterials Market Restraints
- 6 Market Competitive Landscape by Players
- 6.1 Global Top New Medical Materials and Biomaterials Players by Revenue
- 6.1.1 Global Top New Medical Materials and Biomaterials Players by Revenue (2019-2024)
- 6.1.2 Global New Medical Materials and Biomaterials Revenue Market Share by Players (2019-2024)
- 6.2 Global New Medical Materials and Biomaterials Industry Players Ranking, 2022 VS 2023 VS 2024
- 6.3 Global Key Players of New Medical Materials and Biomaterials Head office and Area Served
- 6.4 Global New Medical Materials and Biomaterials Players, Product Type & Application
- 6.5 Global New Medical Materials and Biomaterials Players, Date of Enter into This Industry
- 6.6 Global New Medical Materials and Biomaterials Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
- 7 North America
- 7.1 North America New Medical Materials and Biomaterials Market Size (2019-2030)
- 7.2 North America New Medical Materials and Biomaterials Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 7.3 North America New Medical Materials and Biomaterials Market Size by Country (2019-2024)
- 7.4 North America New Medical Materials and Biomaterials Market Size by Country (2025-2030)
- 7.5 United States
- 7.6 Canada
- 8 Europe
- 8.1 Europe New Medical Materials and Biomaterials Market Size (2019-2030)
- 8.2 Europe New Medical Materials and Biomaterials Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 8.3 Europe New Medical Materials and Biomaterials Market Size by Country (2019-2024)
- 8.4 Europe New Medical Materials and Biomaterials Market Size by Country (2025-2030)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Russia
- 8.10 Nordic Countries
- 9 Asia-Pacific
- 9.1 Asia-Pacific New Medical Materials and Biomaterials Market Size (2019-2030)
- 9.2 Asia-Pacific New Medical Materials and Biomaterials Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 9.3 Asia-Pacific New Medical Materials and Biomaterials Market Size by Country (2019-2024)
- 9.4 Asia-Pacific New Medical Materials and Biomaterials Market Size by Country (2025-2030)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 Southeast Asia
- 9.9 India
- 9.10 Australia
- 10 Latin America
- 10.1 Latin America New Medical Materials and Biomaterials Market Size (2019-2030)
- 10.2 Latin America New Medical Materials and Biomaterials Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 10.3 Latin America New Medical Materials and Biomaterials Market Size by Country (2019-2024)
- 10.4 Latin America New Medical Materials and Biomaterials Market Size by Country (2025-2030)
- 10.5 Mexico
- 10.6 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa New Medical Materials and Biomaterials Market Size (2019-2030)
- 11.2 Middle East & Africa New Medical Materials and Biomaterials Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 11.3 Middle East & Africa New Medical Materials and Biomaterials Market Size by Country (2019-2024)
- 11.4 Middle East & Africa New Medical Materials and Biomaterials Market Size by Country (2025-2030)
- 11.5 Turkey
- 11.6 Saudi Arabia
- 11.7 UAE
- 12 Players Profiled
- 12.1 STR
- 12.1.1 STR Company Information
- 12.1.2 STR Business Overview
- 12.1.3 STR Revenue in New Medical Materials and Biomaterials Business (2019-2024)
- 12.1.4 STR New Medical Materials and Biomaterials Product Portfolio
- 12.1.5 STR Recent Developments
- 12.2 Avitus
- 12.2.1 Avitus Company Information
- 12.2.2 Avitus Business Overview
- 12.2.3 Avitus Revenue in New Medical Materials and Biomaterials Business (2019-2024)
- 12.2.4 Avitus New Medical Materials and Biomaterials Product Portfolio
- 12.2.5 Avitus Recent Developments
- 12.3 Sagemax
- 12.3.1 Sagemax Company Information
- 12.3.2 Sagemax Business Overview
- 12.3.3 Sagemax Revenue in New Medical Materials and Biomaterials Business (2019-2024)
- 12.3.4 Sagemax New Medical Materials and Biomaterials Product Portfolio
- 12.3.5 Sagemax Recent Developments
- 12.4 Stratasys
- 12.4.1 Stratasys Company Information
- 12.4.2 Stratasys Business Overview
- 12.4.3 Stratasys Revenue in New Medical Materials and Biomaterials Business (2019-2024)
- 12.4.4 Stratasys New Medical Materials and Biomaterials Product Portfolio
- 12.4.5 Stratasys Recent Developments
- 12.5 Formlab
- 12.5.1 Formlab Company Information
- 12.5.2 Formlab Business Overview
- 12.5.3 Formlab Revenue in New Medical Materials and Biomaterials Business (2019-2024)
- 12.5.4 Formlab New Medical Materials and Biomaterials Product Portfolio
- 12.5.5 Formlab Recent Developments
- 12.6 NanoH2O (LG)
- 12.6.1 NanoH2O (LG) Company Information
- 12.6.2 NanoH2O (LG) Business Overview
- 12.6.3 NanoH2O (LG) Revenue in New Medical Materials and Biomaterials Business (2019-2024)
- 12.6.4 NanoH2O (LG) New Medical Materials and Biomaterials Product Portfolio
- 12.6.5 NanoH2O (LG) Recent Developments
- 12.7 Covalent-coating
- 12.7.1 Covalent-coating Company Information
- 12.7.2 Covalent-coating Business Overview
- 12.7.3 Covalent-coating Revenue in New Medical Materials and Biomaterials Business (2019-2024)
- 12.7.4 Covalent-coating New Medical Materials and Biomaterials Product Portfolio
- 12.7.5 Covalent-coating Recent Developments
- 12.8 Nasseo
- 12.8.1 Nasseo Company Information
- 12.8.2 Nasseo Business Overview
- 12.8.3 Nasseo Revenue in New Medical Materials and Biomaterials Business (2019-2024)
- 12.8.4 Nasseo New Medical Materials and Biomaterials Product Portfolio
- 12.8.5 Nasseo Recent Developments
- 12.9 TriboFilm
- 12.9.1 TriboFilm Company Information
- 12.9.2 TriboFilm Business Overview
- 12.9.3 TriboFilm Revenue in New Medical Materials and Biomaterials Business (2019-2024)
- 12.9.4 TriboFilm New Medical Materials and Biomaterials Product Portfolio
- 12.9.5 TriboFilm Recent Developments
- 12.10 ACS material
- 12.10.1 ACS material Company Information
- 12.10.2 ACS material Business Overview
- 12.10.3 ACS material Revenue in New Medical Materials and Biomaterials Business (2019-2024)
- 12.10.4 ACS material New Medical Materials and Biomaterials Product Portfolio
- 12.10.5 ACS material Recent Developments
- 12.11 Palmaz Scientific
- 12.11.1 Palmaz Scientific Company Information
- 12.11.2 Palmaz Scientific Business Overview
- 12.11.3 Palmaz Scientific Revenue in New Medical Materials and Biomaterials Business (2019-2024)
- 12.11.4 Palmaz Scientific New Medical Materials and Biomaterials Product Portfolio
- 12.11.5 Palmaz Scientific Recent Developments
- 12.12 Invibio
- 12.12.1 Invibio Company Information
- 12.12.2 Invibio Business Overview
- 12.12.3 Invibio Revenue in New Medical Materials and Biomaterials Business (2019-2024)
- 12.12.4 Invibio New Medical Materials and Biomaterials Product Portfolio
- 12.12.5 Invibio Recent Developments
- 12.13 Secant Medical
- 12.13.1 Secant Medical Company Information
- 12.13.2 Secant Medical Business Overview
- 12.13.3 Secant Medical Revenue in New Medical Materials and Biomaterials Business (2019-2024)
- 12.13.4 Secant Medical New Medical Materials and Biomaterials Product Portfolio
- 12.13.5 Secant Medical Recent Developments
- 12.14 TeraPore Technologies
- 12.14.1 TeraPore Technologies Company Information
- 12.14.2 TeraPore Technologies Business Overview
- 12.14.3 TeraPore Technologies Revenue in New Medical Materials and Biomaterials Business (2019-2024)
- 12.14.4 TeraPore Technologies New Medical Materials and Biomaterials Product Portfolio
- 12.14.5 TeraPore Technologies Recent Developments
- 13 Report Conclusion
- 14 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.